Related Experiment Video

Updated: Jun 7, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Evolution of chronic hypertensive nephropathies treated with ACE inhibitors on patients in pre-dialysis stage

Andreea-Cristina Costea1, D O Costea, Cristiana David

  • 1Nephrology Clinic, "Sf. Loan" Hospital, Bucharest, Romania. acostea100@yahoo.com7

Journal of Medicine and Life
|October 26, 2010
PubMed

Insights

Arterial hypertension management requires careful consideration of angiotensin conversion enzyme (ACE) inhibitor side effects. Close patient monitoring is crucial to prevent complications in chronic kidney disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Arterial hypertension is a primary driver of chronic nephropathy progression.
  • Angiotensin conversion enzyme (ACE) inhibitors are widely used antihypertensives with known side effects.

Purpose of the Study:

  • To evaluate the clinical and paraclinical effects of ACE inhibitors in patients with arterial hypertension and chronic nephropathies.
  • To assess the impact of ACE inhibitors on renal function and cardiac structure.

Main Methods:

  • Clinical and paraclinical evaluation.
  • Monitoring of serum creatinine, natriuresis, and diuresis.
  • Cardiac cavity measurements.

Main Results:

  • ACE inhibitors can influence serum creatinine, natriuresis, and diuresis.
  • Cardiac cavity dimensions may be affected by ACE inhibitor treatment.
  • Variations in these parameters indicate potential complications.

Conclusions:

  • The decision to use ACE inhibitors requires careful justification.
  • Close patient monitoring is essential to mitigate risks and prevent disease complications.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...